Home › Funds › Atom Investors LP › SUPN
Atom Investors LP position in SUPN
SUPERNUS PHARMACEUTICALS · Health Care
Atom Investors LP reported holding 79,936 shares of SUPN (SUPERNUS PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$3.7M, representing 0.33% of its reported portfolio and ranking #42 among its reported holdings. Atom Investors LP has disclosed SUPN holdings in 7 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Atom Investors LP's SUPN position evolved
Atom Investors LP first disclosed a stake in SUPN in Q2 2024 at 9,106 shares (US$244K). The position peaked in Q2 2026 at 79,936 shares, worth US$3.7M. Across 7 filings, Atom Investors LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 79,936 shares valued at US$3.7M — an increase of 34,187 shares quarter over quarter.. Notable position changes include a 913% increase in Q1 2026 (shares fell 10% over the following quarter), a 75% increase in Q2 2026 (shares fell 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 9.11K | $243.59K | New |
| Q3 2024 | 9.28K | $289.26K | Add |
| Q4 2024 | 9.21K | $333.21K | Reduce |
| Q1 2025 | 8.79K | $288.04K | Reduce |
| Q4 2025 | 4.52K | $224.44K | New |
| Q1 2026 | 45.75K | $2.36M | Add |
| Q2 2026 | 79.94K | $3.72M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SUPN and 13F data
SUPN (SUPERNUS PHARMACEUTICALS) is a Health Care company. 35 other funds we track also report a position in SUPN — the largest reported positions include MILLENNIUM MANAGEMENT LLC (US$179.2M), ARMISTICE CAPITAL, LLC (US$123.1M), Sofinnova Investments, Inc. (US$48.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SUPN
- MILLENNIUM MANAGEMENT LLC 3.85M sh · $179.21M · Q2 2026
- ARMISTICE CAPITAL, LLC 2.65M sh · $123.07M · Q2 2026
- Sofinnova Investments, Inc. 1.04M sh · $48.20M · Q2 2026
- ASHFORD CAPITAL MANAGEMENT INC 613.78K sh · $28.55M · Q2 2026
- Soleus Capital Management, L.P. 520.00K sh · $24.19M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 490.22K sh · $22.80M · Q2 2026
More on Atom Investors LP
FAQ
How long has Atom Investors LP held SUPN?
Atom Investors LP has disclosed SUPN holdings in 7 of the last 9 reported quarters, going back to Q2 2024.
What is Atom Investors LP's current position in SUPN?
As of Q2 2026, Atom Investors LP holds 79.94K shares of SUPN (SUPERNUS PHARMACEUTICALS), valued at $3.72M, representing 0.33% of its reported portfolio and ranking #42.
Has Atom Investors LP been buying or selling SUPN?
In the latest 13F filing (Q2 2026), Atom Investors LP increased its position in SUPN. The position peaked in Q2 2026 at 79.94K shares.
Which other funds hold SUPN?
Other major institutional holders of SUPN include MILLENNIUM MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, Sofinnova Investments, Inc., among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.